COURTNEY NUCKOLS: Open Payments
NPI 1659963072 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 16 payments from 8 companies in 2025. Trend: 2023 $305 · 2024 $256 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $144 |
| Mallinckrodt Hospital Products Inc. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: JYNARQUE, TERLIVAZ, Kerendia, TARPEYO, KEVEYIS, Ozempic, FARXIGA, BENLYSTA.
Industry payments across GA — which companies pay providers there.
